| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Expression through RhoA Activation in Trophoblast Cells
Department of Obstetrics and Gynecology (M.H., M.S., T.T., M.T., R.M., A.I., K.T., Y.M.), Osaka University Faculty of Medicine, Suita, Osaka 565-0871, Japan; and Osaka Medical Center for Cancer and Cardiovascular Diseases (T.Y.), Higashinari-ku, Osaka 537-0025, Japan
Address all correspondence and requests for reprints to: Masahiro Sakata, M.D., Ph.D., Department of Obstetrics and Gynecology, Osaka University, Faculty of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail: msakata{at}gyne.med.osaka-u.ac.jp.
During early pregnancy, trophoblast cells are exposed to relatively low-oxygen tension. Recently, the Rho GTPase family has been shown to play a key role in hypoxia-inducible factor-1 (HIF-1)
induction in renal cell carcinoma. The present study was designed to investigate the effect of low-oxygen conditions on RhoA expression in trophoblast cells isolated from early stages of human placenta and in trophoblast-derived BeWo cells and JAR cells. Immunoblot and RT-PCR analyses showed that low-oxygen conditions (1% O2 or 250 µM CoCl2) stimulated expression of RhoA protein and mRNA. Pull-down assays demonstrated that these low-oxygen conditions increased RhoA activity. Preincubation of BeWo cells with Clostridium botulinum C3 exoenzyme, a specific inhibitor of Rho, inhibited hypoxia-induced HIF-1
expression. Under 1% O2 or 250 µM CoCl2, BeWo cells, transfected with a dominant-negative RhoA, exhibited decreased levels of HIF-1
protein and mRNA compared with the control vector transfectants. BeWo cells expressing constitutively active RhoA showed enhanced protein levels of not only HIF-1
but also vascular endothelial growth factor (VEGF) and glucose transporter 1, which are target gene products of HIF-1
. These findings suggest that up-regulation of RhoA induced by low-oxygen conditions may play an important role in regulation of HIF-1
expression in trophoblast cells.
This article has been cited by other articles:
![]() |
W. H. Lee, Y. W. Kim, J. H. Choi, S. C. Brooks III, M.-O. Lee, and S. G. Kim Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1{alpha} activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effect Mol. Cancer Ther., October 1, 2009; 8(10): 2791 - 2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nishimoto, M. Sakata, R. Minekawa, Y. Okamoto, A. Miyake, A. Isobe, T. Yamamoto, T. Takeda, E. Ishida, K. Sawada, et al. Metal Transcription Factor-1 Is Involved in Hypoxia-Dependent Regulation of Placenta Growth Factor in Trophoblast-Derived Cells Endocrinology, April 1, 2009; 150(4): 1801 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takata, K.-i. Morishige, T. Takahashi, K. Hashimoto, S. Tsutsumi, L. Yin, T. Ohta, J. Kawagoe, K. Takahashi, and H. Kurachi Fasudil-induced hypoxia-inducible factor-1{alpha} degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells Mol. Cancer Ther., June 1, 2008; 7(6): 1551 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Anand, S. C. Gribar, J. Li, J. W. Kohler, M. F. Branca, T. Dubowski, C. P. Sodhi, and D. J. Hackam Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1{alpha}-dependent manner J. Leukoc. Biol., November 1, 2007; 82(5): 1257 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Armant, B. A. Kilburn, A. Petkova, S. S. Edwin, Z. M. Duniec-Dmuchowski, H. J. Edwards, R. Romero, and R. E. Leach Human trophoblast survival at low oxygen concentrations requires metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor Development, February 15, 2006; 133(4): 751 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hayashi, M. Sakata, T. Takeda, M. Tahara, T. Yamamoto, Y. Okamoto, R. Minekawa, A. Isobe, M. Ohmichi, K. Tasaka, et al. Up-Regulation of c-met Protooncogene Product Expression through Hypoxia-Inducible Factor-1{alpha} Is Involved in Trophoblast Invasion under Low-Oxygen Tension Endocrinology, November 1, 2005; 146(11): 4682 - 4689. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |